Skip to content

Research for AECOPD individualized treatment in China Jiangnan

Research for AECOPD individualized treatment in China Jiangnan

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003184
Enrollment
Unknown
Registered
2013-04-08
Start date
2013-04-08
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

inhaled drug:standed therapy
venus drug:standed therapy

Sponsors

The 9th Wu'Xi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Explicit history of COPD, In accordance with the AECOPD diagnosis standards (GOLD2011); 2. In the course of 10-20 years; 3. By the age of 50-70 years old; 4. Smoking history >=10 pack-years and <=50 pack-years; 5. FEV1/FVC ratio <=70%; 6. 50% predicted value <=FEV1 <=80% predicted value; 7. In the past three years, exacerbations more than one time per year, presence of more than one time the antibiotic treatment of acute exacerbation in the past year.

Exclusion criteria

Exclusion criteria: 1. no other lung diseases, irregular oxygen therapy, use of oral steroids, high-dose ICS or antibiotics in the 4 weeks prior to the start of the trial; 2. no high blood pressure, diabetes, heart failure, renal insufficiency, hepatic dysfunction following disease history; 3. no pulmonary heart disease, heart failure and other complications; 4. the chest X-ray to exclude pneumonia; 5. no or mild fever (body temperature does not exceed 37.5 degree C).

Design outcomes

Primary

MeasureTime frame
Inflammatory factors;lung function;HRC;

Countries

China

Contacts

Public ContactMin Mao
mao_min@live.cn+86 15951580626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026